Company Filing History:
1 out of 15 
1 out of 4 Years Active: 2012
Title: Nerea Huarte Arrayago: Innovator in HIV Research
Introduction
Nerea Huarte Arrayago is a notable inventor based in Vizcaya, Spain. She has made significant contributions to the field of medical research, particularly in the development of therapies against HIV. Her innovative work has led to the creation of a patent that addresses critical challenges in retroviral infections.
Latest Patents
Nerea Huarte Arrayago holds a patent for "Non-proteolysable oligopeptides that inhibit glycoprotein GP41 of the AIDS virus." This invention focuses on the identification of oligopeptides, especially hexapeptides, that inhibit the binding of retroviruses to target cells. The patent emphasizes the use of D-hexapeptides as potential prophylactic or therapeutic agents against HIV-1, providing new avenues for treatment.
Career Highlights
Throughout her career, Nerea has worked with prestigious institutions such as the University of the Basque Country and the University of Valencia. Her research has been pivotal in advancing our understanding of HIV and developing innovative therapeutic strategies.
Collaborations
Nerea has collaborated with esteemed colleagues, including Jose Luis Nieva Escandon and Maria Jose Gomara Elena. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Nerea Huarte Arrayago's contributions to HIV research through her patented inventions highlight her role as a leading innovator in the field. Her work continues to inspire advancements in medical therapies for retroviral infections.